William Hankey

1.1k total citations
24 papers, 664 citations indexed

About

William Hankey is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, William Hankey has authored 24 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in William Hankey's work include Prostate Cancer Treatment and Research (7 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related gene regulation (4 papers). William Hankey is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related gene regulation (4 papers). William Hankey collaborates with scholars based in United States, China and France. William Hankey's co-authors include Joanna Groden, Wendy L. Frankel, Qianben Wang, Fuwen Yuan, Zhong Chen, Xiaosheng Fang, Qianqian Zhou, Yanhua Chen, Wei Li and Jiaoti Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

William Hankey

23 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Hankey United States 12 446 231 162 137 72 24 664
Kang‐Lai Wei China 13 441 1.0× 148 0.6× 325 2.0× 202 1.5× 37 0.5× 27 680
Feihu Bai China 17 419 0.9× 86 0.4× 200 1.2× 177 1.3× 40 0.6× 48 694
Daniela Frezzetti Italy 13 358 0.8× 110 0.5× 266 1.6× 175 1.3× 27 0.4× 18 613
Lixun Chai China 5 271 0.6× 243 1.1× 95 0.6× 162 1.2× 76 1.1× 6 530
Ren Jie Jin United States 12 339 0.8× 298 1.3× 178 1.1× 180 1.3× 98 1.4× 17 640
Alicia de las Pozas United States 12 337 0.8× 133 0.6× 106 0.7× 112 0.8× 56 0.8× 16 490
Wei Jing China 16 341 0.8× 199 0.9× 111 0.7× 269 2.0× 23 0.3× 45 694
Ursula Cesta Incani Italy 7 489 1.1× 106 0.5× 188 1.2× 187 1.4× 28 0.4× 9 703
Junaid Abdulghani United States 11 424 1.0× 159 0.7× 165 1.0× 323 2.4× 91 1.3× 14 739
Núria Eritja Spain 18 449 1.0× 63 0.3× 202 1.2× 191 1.4× 54 0.8× 40 768

Countries citing papers authored by William Hankey

Since Specialization
Citations

This map shows the geographic impact of William Hankey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Hankey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Hankey more than expected).

Fields of papers citing papers by William Hankey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Hankey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Hankey. The network helps show where William Hankey may publish in the future.

Co-authorship network of co-authors of William Hankey

This figure shows the co-authorship network connecting the top 25 collaborators of William Hankey. A scholar is included among the top collaborators of William Hankey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Hankey. William Hankey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hankey, William, et al.. (2025). Programmed Cell Death in Cancer. MedComm. 6(9). e70357–e70357. 1 indexed citations
2.
Cui, Zhifen, Furong Huang, Kun Fang, et al.. (2025). SCORT–Cas13d Nanotherapy Precisely Targets the ‘Undruggable’ Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo. Advanced Science. 12(23). e2417605–e2417605. 2 indexed citations
3.
Huang, Furong, Kexin Li, Zhong Chen, et al.. (2024). Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer. Oncogene. 44(8). 481–493. 2 indexed citations
4.
Cui, Zhifen, Furong Huang, Kun Fang, et al.. (2024). Abstract 495: Targeting undruggable transcription factor HOXB13 in metastatic prostate cancer by CRISPR/Cas13d-based nanoparticle therapy. Cancer Research. 84(6_Supplement). 495–495.
5.
Hankey, William, Shannon McNulty, Xiao Peng, et al.. (2023). CTLA4 variant curation using adapted ACMG/AMP guidelines. Clinical Immunology. 250. 109425–109425. 1 indexed citations
6.
Cui, Zhifen, Cong Zeng, Furong Huang, et al.. (2022). Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Nature Chemical Biology. 18(10). 1056–1064. 39 indexed citations
7.
Suh, Yewseok, et al.. (2022). Introducing Wound Healing Assays in the Undergraduate Biology Laboratory Using Ibidi Plates. Journal of Microbiology and Biology Education. 23(2). 9 indexed citations
8.
Chen, Yanhua, Qianqian Zhou, William Hankey, Xiaosheng Fang, & Fuwen Yuan. (2022). Second generation androgen receptor antagonists and challenges in prostate cancer treatment. Cell Death and Disease. 13(7). 632–632. 76 indexed citations
9.
Chen, Zhong, William Hankey, Yue Zhao, et al.. (2021). Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling. Nature Communications. 12(1). 6318–6318. 8 indexed citations
10.
Hankey, William, Zhong Chen, & Qianben Wang. (2020). Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors. Cancer Research. 80(12). 2427–2436. 49 indexed citations
11.
Hankey, William, et al.. (2020). Using The Cancer Genome Atlas as an Inquiry Tool in the Undergraduate Classroom. Frontiers in Genetics. 11. 573992–573992. 6 indexed citations
12.
Hankey, William, Benjamin Sunkel, Fuwen Yuan, et al.. (2020). Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range. Translational Oncology. 13(9). 100797–100797. 8 indexed citations
13.
Yuan, Fuwen, William Hankey, Eric J. Wagner, Wei Li, & Qianben Wang. (2019). Alternative polyadenylation of mRNA and its role in cancer. Genes & Diseases. 8(1). 61–72. 63 indexed citations
14.
Yuan, Fuwen, William Hankey, Dayong Wu, et al.. (2019). Molecular determinants for enzalutamide-induced transcription in prostate cancer. Nucleic Acids Research. 47(19). 10104–10114. 31 indexed citations
15.
Hankey, William, Wendy L. Frankel, & Joanna Groden. (2018). Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer and Metastasis Reviews. 37(1). 159–172. 135 indexed citations
16.
Hankey, William, Michael A. McIlhatton, Brian Kennedy, et al.. (2017). Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients. Cancer Research. 78(3). 617–630. 12 indexed citations
17.
Lu, Yuanzhi, WU Yong-sheng, Xiaoling Feng, et al.. (2014). CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis. Journal of Clinical Investigation. 124(4). 1672–84. 16 indexed citations
18.
19.
Yong-sheng, WU, Xiaoling Feng, Yucui Jin, et al.. (2010). A Novel Mechanism of Indole-3-Carbinol Effects on Breast Carcinogenesis Involves Induction of Cdc25A Degradation. Cancer Prevention Research. 3(7). 818–828. 21 indexed citations
20.
Li, Shyr‐Jiann, William Hankey, & Mark Hochstrasser. (2005). Preparation and Characterization of Yeast and Human Desumoylating Enzymes. Methods in enzymology on CD-ROM/Methods in enzymology. 398. 457–467. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kang‐Lai Wei Breakdown of academic impact, for papers by Feihu Bai Breakdown of academic impact, for papers by Daniela Frezzetti Breakdown of academic impact, for papers by Lixun Chai Breakdown of academic impact, for papers by Ren Jie Jin Breakdown of academic impact, for papers by Alicia de las Pozas Breakdown of academic impact, for papers by Wei Jing Breakdown of academic impact, for papers by Ursula Cesta Incani Breakdown of academic impact, for papers by Junaid Abdulghani Breakdown of academic impact, for papers by Núria Eritja
Rankless by CCL
2026